Before I start I should state that I am a Buddy shareholder with a substantial shareholding (for me anyway), and I am in no way trying to ramp another stock. I have listened to DM's comments about not releasing data about trials and install's, and accepted his view while not being totally comfortable with it.
I read the quarterly report put out by BIQ, primarily because of the air it has been give by one of our forum members who I have previously put on ignore. The report went into great detail about how many new trials it had started, how many contracts it had signed, etc. I was really impressed, and so were the followers on their forum.
I can't make the webinar but if I could I would raise this issue again as I see it as really the only weak point in Buddies communication with the shareholders. Maybe the webinar will reveal some of this information, if not, maybe someone who is attending the webinar will raise it again.
BUD Price at posting:
19.5¢ Sentiment: Buy Disclosure: Held